Market news
This under-the-radar cybersecurity stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Cellebrite DI (CLBT) sits in focus after recent share performance left the stock down over the past year, despite revenue of US$514.289m and net income of US$58.246m from its digital investigations platform. Cellebrite DI’s share price has slipped over recent months, with the stock down 35.2% year to date and 9.26% over the past quarter, even though the 30 day share price return of 4.62% shows a short burst of positive momentum against a weaker near term trend. Scan beyond Cellebrite DI and...
Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered digital investigative and intelligence solutions for the public and private sectors, today announced the expansion of The 101, a purpose-built global digital community for digital forensics and investigative professionals available to customers through the MyCellebrite portal. The community is growing daily from a base of 62-thousand users who are in active discussion groups, asking questions and sharing knowledge with peers and Ce
Detailed price information for Life360 Inc (LIF-Q) from The Globe and Mail including charting and trades.
Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered digital investigative and intelligence solutions, today announced expanded resources and new leadership for Cellebrite Labs, the team responsible for much of the core mobile research behind the company's access, extraction and decoding technology. Effective immediately, Cellebrite Labs is operating under the leadership of Chris Wade, Cellebrite's Chief Technology Officer, and is now part of the company's Innovation Hub that Wade ha
Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, announced today that the Company's Board of Directors has authorized Cellebrite to pursue a corporate reorganization, establishing a new United States corporation as the ultimate parent company, subject to shareholder and regulatory approvals.
Cellebrite DI's (CLBT) board has approved a corporate reorganization, under which it will establish
Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company plans to participate in two upcoming investor events later this month.
Tipranks Press Release.
Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that Cellebrite Guardian, its cloud-based digital evidence management platform, has achieved an important technical milestone to support its adoption by the Company's customers in Australia. Guardian has completed an assessment under the Infosec Registered Assessors Program (IRAP) at the PROTECTED classification level. The assessmen
Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the launch of the Cellebrite Tactical Extraction Kit (C-TEK), a ruggedized, all-in-one mobile forensics field kit packaged in a standard-size backpack, giving military teams the hardware, software and power to access and analyze devices at the point of capture. Designed for units operating in disconnected environments, C-TEK equips
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
On August 13, Cellebrite (NASDAQ:CLBT) named a new chief executive and trimmed its full-year outlook on the same morning. Shiven Ramji stepped in as CEO effective that day, replacing Tom Hogan, while the company lowered its 2026 revenue and ARR targets after several large government deals slipped past the quarter. Management highlighted positive growth drivers […]
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Cellebrite DI (CLBT) said Wednesday its Genesis investigation platform is now generally available to
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, […]
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Stratasys Ltd (SSYS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.
Cellebrite DI (CLBT) has come under fresh scrutiny after its August 13 Q2 2026 earnings report, guidance cut, and CEO transition, with Levi & Korsinsky launching an investigation following a sharp post results share price decline. See our latest analysis for Cellebrite DI. Cellebrite DI’s latest earnings miss, guidance reset and CEO change have coincided with sharp selling, with the share price down 29.18% over one day and 33.25% over 30 days, while the 3 year total shareholder return remains...
In August 2026, Cellebrite DI Ltd. reported second-quarter results showing revenue of US$131.14 million and net income of US$6.37 million, while lowering its full-year 2026 revenue guidance to US$555 million–US$561 million and announcing Shiven Ramji’s appointment as CEO, succeeding Thomas E. Hogan. The combination of reduced revenue expectations, softer profitability, and a leadership transition raises questions about how quickly Cellebrite can convert its product and AI investments,...
This is the newest page. Registered accounts read further back.